Cabaletta Bio, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $106.7M | $59.6M |
| Jun 2022 | — | $95.5M | $47.2M |
| Sep 2022 | — | $85.9M | $61.2M |
| Dec 2022 | — | $104.5M | $81.6M |
| Mar 2023 | — | $91.7M | $93.8M |
| Jun 2023 | — | $174.1M | $128.1M |
| Sep 2023 | — | $160.9M | $115.5M |
| Dec 2023 | — | $236.2M | $193.2M |
| Mar 2024 | — | $221.7M | $175.3M |
| Jun 2024 | — | $199.5M | $178.6M |
| Sep 2024 | — | $174.2M | $170.6M |
| Dec 2024 | — | $152.3M | $164.0M |
| Mar 2025 | — | $121.6M | $131.8M |
| Jun 2025 | — | $178.5M | $145.6M |
| Sep 2025 | — | $139.5M | $60.2M |
| Dec 2025 | — | $112.1M | $83.0M |
| Mar 2026 | — | $103.3M | $116.6M |
| Jun 2026 | — | $210.6M | $225.1M |